RECRUITING

Prospective Investigation of Multiple Sclerosis in the Three Rivers Region

Talk to us

Conditions

Multiple Sclerosis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.

Official Title

Prospective Investigation of Multiple Sclerosis in the Three Rivers Region

Quick Facts

Study Start:2016-12
Study Completion:2047-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02994121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Inclusion criteria for MS patients include:
  2. 1. willing and able to give consent
  3. 2. age 7 years or older
  4. 3. diagnosis of multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
  5. * For healthy controls:
  6. 1. Age 7 years or older
  7. 2. Willing and able to provide consent (for \>=18 years) or assent with permission from at least one of the child's parents (for \<18 years)
  8. 3. No known personal history of multiple sclerosis or related disorders
  9. 4. No other chronic diseases
  10. 5. Family members, unrelated household controls, or controls from the general population could be eligible
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Zongqi Xia, MD, PhD
CONTACT
412-383-5377
msstudy2@pitt.edu

Principal Investigator

Zongqi Xia, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh
Pittsburgh, Pennsylvania, 15260
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Zongqi Xia, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-12
Study Completion Date2047-01

Study Record Updates

Study Start Date2016-12
Study Completion Date2047-01

Terms related to this study

Additional Relevant MeSH Terms

  • Multiple Sclerosis